News - Genentech

Filter

Current filters:

Genentech

Popular Filters

46 to 60 of 60 results

Roche in epigenetics drug discovery collaboration

18-01-2012

USA-based Constellation Pharmaceuticals says that it has entered into a major strategic agreement with…

BiotechnologyConstellation PharmaceuticalsGenentechLicensingMergers & AcquisitionsOncologyPharmaceuticalRoche

Xenon in $646 million deal with Roche unit

10-01-2012

Canada based Xenon Pharmaceuticals, a privately-owned, clinical genetics-based drug discovery and development…

BiotechnologyGenentechLicensingNeurologicalPharmaceuticalResearchRocheXenon Pharmaceuticals

Vernalis jumps on deal with Genentech

05-01-2012

The UK's Vernalis (LSE: VER) saw its shares jump more than 5% to 20.75 yesterday, after the company revealed…

FinancialGenentechIpsenLicensingLundbeckPharmaceuticalRocheVernalis

Inhibitors of infamous Ras oncogene reported by Genentech researchers

04-12-2011

A drug discovery team at Genentech, a subsidiary of Swiss drug major Roche (ROG: SIX) has uncovered a…

BiotechnologyGenentechOncologyPharmaceuticalResearchRoche

US FDA revokes Roche/Genentech Avastin license for metastatic breast cancer

21-11-2011

After months of deliberations, the US Food and Drug Administration (FDA Commissioner is revoking the…

AvastinBiotechnologyGenentechNorth AmericaOncologyPharmaceuticalRegulationRoche

US court rules in GlaxoSmithKline’s favor in Arzerra patent dispute

18-11-2011

A US District Court has entered final judgment in favor of UK pharma giant GlaxoSmithKline (LSE: GSK)…

ArzerraBiogen IdecBiotechnologyGenentechGenmabGlaxoSmithKlineLegalNorth AmericaOncologyPatentsPharmaceuticalRoche

FDA priority review for Roche/Genentech’s vismodegib for skin cancer

10-11-2011

The US Food and Drug Administration has accepted and filed Swiss drug major Roche (ROG: SIX) subsidiary…

BiotechnologyCurisGenentechNorth AmericaOncologyPharmaceuticalRegulationRochevismodegib

Genentech files with US FDA for vismodegib in rare form of advanced skin cancer

13-09-2011

In a second filing for a novel skin cancer drug this year, Swiss drug major Roche (ROG: SIX) US subsidiary…

BiotechnologyCurisGenentechNorth AmericaOncologyPharmaceuticalRegulationRochevismodegib

Galapagos units extend drug discovery collaboration with Genentech

19-08-2011

Galapagos units extend drug discovery collaboration with Genentech August 19, 2011 Belgium-based…

FinancialGalapagosGenentechPharmaceuticalResearchRoche

US Nevada state judge denies Roche and Genentech motions to dismiss PDL BioPharma's royalties complaint

12-07-2011

The Second Judicial District Court of US state Nevada ruled in favor of PD BioPharma (Nasdaq: PDLI) on…

BiotechnologyGenentechLegalNorth AmericaOncologyPDL BioPharmaPharmaceuticalRoche

Roche’s Genentech in preclinical cancer program deal with FORMA Therapeutics

28-06-2011

Cambridge, Massachusetts, USA-based small-molecule therapeutics developer FORMA Therapeutics has entered…

BiotechnologyFORMA TherapeuticsGenentechLicensingOncologyPharmaceuticalRoche

Roche files for US and EU approval of vemurafenib for metastatic skin cancer

12-05-2011

US biotech giant Genentech, part of Swiss drug major Roche (SIX: ROG), has submitted a New Drug Application…

Bristol-Myers SquibbDaiichi SankyoEuropeGenentechNorth AmericaOncologyPharmaceuticalPlexxikonRegulationRochevemurafenibYervoy

46 to 60 of 60 results

Company Spotlight

Fibrotech

Fibrotech

Back to top